NeuroMetrix, Inc.

NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company maintains an active research effort and has several pipeline programs. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit NeuroMetrix.com.NeuroMetrix markets the following products: Quell® Wearable Pain Relief Technology™Quell is 100% drug free wearable technology that has changed the lives of people suffering with chronic pain. It combines clinical strength neurostimulation to treat pain with an easy-to-use app that helps people manage pain and reclaim their lives. Quell is doctor recommended and designed for people with chronic back pain, arthritic pain, nerve pain, leg and foot pain, among other chronic pain conditions. Quell launched in June 2015 and is now commercially available OTC at www.quellrelief.com.SENSUS®The SENSUS pain therapy device is a prescription neurostimulation device based on TENS for relief of chronic, intractable pain. SENSUS is a convenient and wearable device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. DPNCheck®DPNCheck is a fast, accurate, and quantitative nerve conduction test that is used to evaluate systemic neuropathies such as diabetic peripheral neuropathy (DPN). It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor DPN. ADVANCE™ SystemThe ADVANCE System is a platform for the performance of nerve conduction studies. ADVANCE is most commonly used with proprietary nerve specific electrode arrays that combine multiple individual electrodes and embedded microelectronic components into a single patient-use disposable unit.